Exclusive news, data and analytics for financial market professionals
Learn more about
Refinitiv
Skip to main content
Reuters home
World
Business
Markets
Sustainability
Legal
Breakingviews
Technology
Investigations
More
My View
Register
Company
Ucb SA
Follow
6 results
Legal
category
Teva, Viatris win U.S. appeal in patent fight over Parkinson's drug
April 12, 2023
World
category
U.S. Parkinson's disease incidence far higher than earlier estimates, study shows
December 15, 2022
Markets
category
European stocks close above three-month high on Powell, China cheer
December 1, 2022
Business
category
U.S. FDA approves UCB's drug for rare childhood epilepsy
March 28, 2022
Business
category
Epilepsy drug maker Zogenix soars on UCB's potential $2 bln deal
January 19, 2022
Business
category
Llama antibodies blunt COVID variants in lab trial, says Belgian start-up
August 24, 2021
article with video
1 to 6 of 6
